Lung cancer trials in Taiwan
144 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 12 years and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - Phase 1Taking peopleA Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
- Where
- Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391670 · EU 2025-521639-34-00 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Where
- Tainan, Taipei
- Age
- 18 years and over
- People
- 416 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06618287 - Phase 2Taking peoplePrimary Tumor Resection With EGFR TKI for Stage IV NSCLC
- Where
- Taipei
- Age
- 20 years and over
- People
- 100
- Run by
- National Taiwan University Hospital
See details and how to joinNCT05215548 - Phase 1Taking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Where
- Taipei
- Age
- 18 years and over
- People
- 232 worldwide
- Run by
- AbbVie
See details and how to joinNCT06858813 · EU 2024-518012-39-00 - Phase 3Taking peopleOsimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer
- Where
- Taipei
- Age
- 18 years and over
- People
- 154
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07738172 - No phaseTaking peopleThe Effects of Low Intensity Endurance Exercise on Improving Mitochondrial Function, Cell Bioelectrical Impedance Phase Angle, Fatigue and Quality of Life in Lung Cancer Patients With Cancer-related Fatigue
- Where
- Taipei
- Age
- 20 years to 70 years
- People
- 150
- Run by
- Taipei Medical University
See details and how to joinNCT07806682 - Phase 1Taking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Taipei
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - Phase 1/2Taking peopleStudy of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
- Where
- Taipei
- Age
- 18 years and over
- People
- 171 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00 - No phaseTaking peopleThe Effects of Low-Intensity Endurance Exercise on Improving Fatigue, Sleep, Quality of Life, Mitochondrial Function, Cellular Bioelectrical Impedance Phase Angle, and Predictors of Exercise Adherence in Patients With Lung Cancer
- Where
- Taipei
- Age
- 20 years and over
- People
- 450
- Run by
- Taipei Medical University
See details and how to joinNCT07795580 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Changhua, Kaohsiung City, Taipei
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - Phase 1/2Taking peopleStudy of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Where
- Tainan
- Age
- 18 years to 100 years
- People
- 280 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06726148 · EU 2024-517281-42-00 - Phase 3Taking peoplePhase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Taichung, Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 582 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00 - Phase 1/2Taking peopleA Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Where
- Kaohsiung City, Taichung, Tainan, Taipei
- Age
- 18 years and over
- People
- 594 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06892548 · EU 2024-520238-31-01 - No phaseTaking peopleNitride-Based Raman Biochip for Lung Cancer Diagnosis and Monitoring
- Where
- Taichung
- Age
- 18 years and over
- People
- 3,000
- Run by
- Taichung Veterans General Hospital
See details and how to joinNCT07755020 - No phaseTaking peopleDevelopment and Dissemination of Exercise Prescription and Intervention for Cancer Populations
- Where
- Kaohsiung
- Age
- 18 years to 80 years
- People
- 150
- Run by
- Kaohsiung Medical University Chung-Ho Memorial Hospital
See details and how to joinNCT07751783 - Phase 3Taking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - No phaseTaking peopleCare Needs in Lung Cancer Patients Receiving Immunotherapy
- Where
- Taipei
- Age
- 20 years and over
- People
- 180
- Run by
- National Taiwan University Hospital
See details and how to joinNCT06433206 - Phase 3Taking peoplePhase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Where
- Kaohsiung City, Taichung, Tainan, Taipei, Taipei City, Taoyuan
- Age
- 18 years and over
- People
- 756 worldwide
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06095583 - Phase 2Taking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Tainan, Taipei, Taoyuan County
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - No phaseTaking peopleNurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer
- Where
- Taipei
- Age
- 18 years and over
- People
- 120
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07708870 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Kaohsiung City, Taipei
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1/2Taking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- New Taipei City, Tainan, Taipei
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - Phase 2Taking peopleAumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
- Where
- New Taipei City, Taipei
- Age
- 18 years and over
- People
- 50
- Run by
- Taipei Medical University Hospital
See details and how to joinNCT07624487